NIH Licenses Super Antibodies to Fight Cancer and Autoimmune Woes
Published Date: 4/3/2026
Notice
Summary
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this ready-to-go tech to help patients faster, with some foreign patent options to boost global reach. Interested parties should act soon to get access and start making a difference!
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
NIH Offers Human Antibody Tech for Licensing
The National Institute of Allergy and Infectious Diseases (NIAID/NIH) is offering a set of fully human antibodies (including a potent antibody called NIH58.9) for commercial licensing under HHS Reference No. E-025-2025. The technology is at the pre-clinical stage and is available for companies to license and develop; the U.S. provisional patent application 63/787,190 was filed on April 11, 2025.
Collaboration Opportunity and Confidential Access Requirement
NIAID is seeking statements of capability or interest from parties for collaborative research to further develop, evaluate, or commercialize this antibody technology. A signed Confidential Disclosure Agreement (CDA) is required to receive copies of unpublished information, and interested parties should contact Benjamin Hurley (phone 240-276-5489) and reference E-025-2025.
Foreign Patent Options May Be Licensed
The notice states that foreign patent applications are filed on selected inventions to extend market coverage and those foreign patent rights may also be available for licensing to interested parties. Companies seeking broader geographic protection can inquire about licensing these foreign patent filings.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09808 — Government Owned Inventions Available for License: Synergistic Interactions for Improved Cancer Treatment
The National Cancer Institute is offering a cool new cancer treatment invention called hetIL-15 that works better when combined with other drugs like Fenofibrate and quizartinib. This combo could help patients by making immune cells stronger and safer, potentially beating tough cancers like breast and pancreatic tumors. Researchers and companies interested in developing or licensing this tech should act soon to join the fight against cancer and bring these treatments to life.
2026-09292 — Government Owned Inventions Available for License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1 or TRAT1
The government has a cool new discovery that makes certain immune cells, called T cells, better at fighting cancer by turning off some ‘brakes’ inside them. This could lead to stronger treatments for cancer, infections, and autoimmune diseases. Companies interested in developing this technology can license it now, potentially speeding up new, powerful therapies and boosting health outcomes.
2026-08606 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate grant applications related to aging, genetics, neurodegeneration, and pediatric critical care. These meetings protect sensitive info like trade secrets and personal data, so they’re not open to the public. Researchers applying for grants should note these dates as they impact funding decisions and the review process timeline.
2026-08638 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on grant applications. These meetings affect researchers seeking funding for brain, behavior, and imaging studies, keeping sensitive info private. No new costs or deadlines are announced, but these reviews shape which projects get money next.
2026-08456 — Proposed Collection; 60-Day Comment Request; NIH Office of Intramural Training & Education-Application, Registration, and Alumni Systems Office of the Director
The NIH Office of Intramural Training & Education wants your thoughts on updating their application, registration, and alumni systems. This affects students, trainees, and alumni who use these systems, aiming to make things smoother and less time-consuming. You’ve got 60 days to share your ideas before they finalize the changes—no extra costs involved, just better tech and less hassle!
2026-08461 — Submission for OMB Review; 30-Day Comment Request Application and Impact of Clinical Research Training on Healthcare Professionals in Academia and Clinical Research (Office of the Director)
The NIH is asking for public feedback on a survey about how clinical research training helps healthcare pros in schools and labs. This is a quick 30-day chance to share your thoughts before June 1, 2026. No big costs or changes yet—just making sure the survey is clear and useful for everyone involved.
Previous / Next Documents
Previous: 2026-06500 — Medicare and Medicaid Programs; Approval of Application by the Accreditation Commission for Health Care Inc. (ACHC) for Continued CMS-Approval of its Hospice Accreditation Program
The Accreditation Commission for Health Care Inc. (ACHC) just got the green light to keep accrediting hospice programs that want to work with Medicare and Medicaid from November 27, 2025, to November 27, 2031. This means hospices can keep using ACHC’s stamp of approval instead of state surveys to join or stay in these programs. It’s a smooth win for hospices, patients, and the government, keeping quality care on track without extra hassle or cost.
Next: 2026-06502 — Evaluation of Pennsylvania Coastal Management Program; Notice of Public Meeting; Request for Comments
NOAA is checking how well Pennsylvania’s Coastal Management Program is working and wants your thoughts! They’re hosting a virtual meeting on May 19, 2026, where you can speak up, and you can also send written comments by May 29. This is a great chance for anyone who cares about Pennsylvania’s coast to help shape its future—no money changes yet, just your voice making waves!